Savara (SVRA) Operating Expenses (2010 - 2026)
Savara (SVRA) reported Operating Expenses of $39.0 million for Q1 2026, up 37.12% year-over-year from $28.4 million in Q1 2025, and up 16.67% quarter-over-quarter from $33.4 million in Q4 2025.
Savara (SVRA) Operating Expenses (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Operating Expenses data on file, last reported at $39.0 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $39.0 million, up 37.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $134.1 million (up 22.86% YoY), and the FY2025 annual result was $123.5 million, up 19.72% from the prior year.
- Operating Expenses climbed to $39.0 million in Q1 2026 per SVRA's latest filing, from $33.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $39.0 million in Q1 2026 and troughed at $8.0 million in Q1 2022.
- A 5-year average of $21.4 million and a median of $22.5 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses fell 22.74% in 2022, then surged 89.76% in 2024.
- A 5-year view of Operating Expenses shows it stood at $10.9 million in 2022, then soared by 62.11% to $17.6 million in 2023, then soared by 76.82% to $31.2 million in 2024, then advanced by 7.2% to $33.4 million in 2025, then advanced by 16.67% to $39.0 million in 2026.
- Business Quant data shows SVRA's Operating Expenses at $39.0 million in Q1 2026, $33.4 million in Q4 2025, and $30.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 38.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.99 Mn |
| Dec 31, 2025 | 33.42 Mn |
| Sep 30, 2025 | 30.26 Mn |
| Jun 30, 2025 | 31.44 Mn |
| Mar 31, 2025 | 28.44 Mn |
| Dec 31, 2024 | 31.17 Mn |
| Sep 30, 2024 | 26.36 Mn |
| Jun 30, 2024 | 23.19 Mn |
| Mar 31, 2024 | 22.48 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 18.04 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 12.11 Mn |
| Dec 31, 2022 | 10.88 Mn |
| Sep 30, 2022 | 10.54 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 10.64 Mn |
| Sep 30, 2021 | 9.97 Mn |
| Jun 30, 2021 | 10.45 Mn |